Impact of N -acetyl-l-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study.

Paola FaverioPaola ReboraEmanuela RossiSavino Del GiudiceFilippo MontanelliLaura GarzilloSara BusnelliFabrizio LuppiMaria Grazia ValsecchiAlberto Pesci

Published in: ERJ open research (2021)

Patients receiving N -acetyl-l-cysteine (NAC) during hospitalisation for #SARSCoV2 pneumonia and discharged alive present a significantly shorter length of hospital stay compared to those who did not receive NAC https://bit.ly/3l1QsVo.

Keyphrases

sars cov
transcription factor
fluorescent probe
living cells
healthcare
respiratory syndrome coronavirus
genome wide analysis
respiratory failure
community acquired pneumonia
emergency department
adverse drug
intensive care unit
coronavirus disease
single molecule
mechanical ventilation